文献速递泌尿生殖与妇科肿瘤放疗

学术安全网医院中前列腺癌患者按风险分层的治疗延迟影响因素及治疗类型差异

Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital.
PubMed 文献 · Adv Radiat Oncol · 2017-12-13

该回顾性研究分析了2005年1月至2013年12月在某学术安全网医疗中心诊断的1088例非转移性前列腺癌患者,探讨社会人口学因素与治疗选择及从诊断到治疗时间(TTT)的关系。年龄、种族和婚姻状况与治疗选择显著相关;非白种人和60岁以上患者接受根治性前列腺切除术的可能性较低,黑人患者接受放疗的可能性是白人的3.8倍。中位TTT为75天,高龄、非白种人、非英语使用者、无商业保险及未婚状态患者的延迟更长;高危患者平均TTT较低危患者长25天,放疗患者平均TTT较根治性前列腺切除术患者长34天。

要点

  • 年龄、种族和婚姻状况与前列腺癌治疗选择显著相关。
  • 黑人患者接受放疗的可能性是白人的3.8倍。
  • 高危患者平均TTT较低危患者长25天,放疗患者平均TTT较RP患者长34天。

核心结论

  • 前列腺癌患者的治疗选择和从诊断到治疗时间受年龄、种族、婚姻状况和保险等人口学因素以及疾病分期和风险分级等临床因素影响。

研究设计与样本

  • 回顾性综述,纳入2005年1月至2013年12月在某学术安全网医疗中心诊断的1088例非转移性前列腺癌患者。
  • 收集人口学数据、TTT、初始治疗选择、美国癌症联合委员会分期和国家综合癌症网络风险分级。
  • 采用方差分析和多因素逻辑回归模型分析上述因素与治疗选择和TTT的关系。

主要发现

  • 年龄、种族和婚姻状况与治疗选择显著相关。
  • 非白种人和60岁以上患者接受根治性前列腺切除术的可能性较低。
  • 黑人患者接受放疗的可能性是白人的3.8倍。
  • 中位TTT为75天。
  • 高龄、非白种人、非英语使用者、无商业保险和未婚状态患者的TTT延迟显著更长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Understanding the drivers of delays from diagnosis to treatment can elucidate how to reduce the time to treatment (TTT) in patients with prostate cancer. In addition, the available treatments depending on the stage of cancer can vary widely for many reasons. This study investigated the relationship of TTT and treatment choice with sociodemographic factors in patients with prostate cancer who underwent external beam radiation therapy (RT), radical prostatectomy (RP), androgen deprivation therapy (ADT), or active surveillance (AS) at a safety-net academic medical center. METHODS AND MATERIALS: A retrospective review was performed on 1088 patients who were diagnosed with nonmetastatic prostate cancer between January 2005 and December 2013. Demographic data as well as data on TTT, initial treatment choice, American Joint Committee on Cancer stage, and National Comprehensive Cancer Network risk categories were collected. Analyses of variance and multivariable logistic regression models were performed to analyze the relationship of these factors with treatment choice and TTT. RESULTS: Age, race, and marital status were significantly related to treatment choice. Patients who were nonwhite and older than 60 years were less likely to undergo RP. Black patients were 3.8 times more likely to undergo RT compared with white patients. The median TTT was 75 days. Longer time delays were significant in patients of older age, nonwhite race/ethnicity, non-English speakers, those with noncommercial insurance, and those with non-married status. The average TTT of high-risk patients was 25 days longer than that of low-risk patients. Patients who underwent RT had an average TTT that was 34 days longer than that of RP patients. CONCLUSIONS: The treatment choice and TTT of patients with prostate cancer are affected by demographic factors such as age, race, marital status, and insurance, as well as clinical factors including stage and risk category of disease.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kan CK, Qureshi MM, Gupta A, et al. Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital. Adv Radiat Oncol. 2017. PMID: 29904743. doi:10.1016/j.adro.2017.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。